Reckitt Benckiser Group Given Sell Rating at Liberum Capital (RB)
Reckitt Benckiser Group (LON:RB)‘s stock had its “sell” rating reaffirmed by equities researchers at Liberum Capital in a research report issued on Thursday, Stock Ratings Network.com reports. They currently have a GBX 3,500 ($57.41) price objective on the stock. Liberum Capital’s price objective would suggest a potential downside of 25.18% from the stock’s previous close.
Other equities research analysts have also recently issued reports about the stock. Analysts at Credit Suisse reiterated a “neutral” rating on shares of Reckitt Benckiser Group in a research note to investors on Tuesday. They now have a GBX 4,650 ($76.27) price target on the stock. Finally, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Reckitt Benckiser Group in a research note to investors on Thursday, December 5th. Seven investment analysts have rated the stock with a sell rating, nineteen have issued a hold rating and six have issued a buy rating to the company. Reckitt Benckiser Group currently has a consensus rating of “Hold” and an average target price of GBX 4,648.58 ($76.24).
Reckitt Benckiser Group (LON:RB) opened at 4678.00 on Thursday. Reckitt Benckiser Group has a 1-year low of GBX 3936.00 and a 1-year high of GBX 4986.00. The stock’s 50-day moving average is GBX 4761. and its 200-day moving average is GBX 4643.35. The company’s market cap is £34.174 billion.
Reckitt Benckiser Group Plc is manufacturer and marketer of branded products in household, health and personal care, selling a range through over 60 operating companies into nearly 200 countries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.